FindTrial
Sign In

TO CHECK THE VALUE OF"ADVANCED GLYCATION END PRODUCTS" IN THE GUMS OF TYPE 2 DIABETIC PEOPLE BEFORE AND AFTER PROFESSIONAL TOOTH CLEANING WITH LOW LEVEL LIGHT THERAPY DONE ON ONE SIDE OF THE MOUTH.

COMPARATIVE EVALUATION OF ADVANCED GLYCATION END PRODUCTS IN GINGIVAL CREVICULAR FLUID OF CHRONIC PERIODONTITIS PATIENTS WITH TYPE-II DIABETES MELLITUS BEFORE AND AFTER SCALING AND ROOT PLANING AND WITH LOW LEVEL LASER THERAPY AS AN ADJUNCT.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/03/032251
Enrollment
15
Registered
2021-03-23
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications Health Condition 2: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Scaling And Root Planing Low Level Laser Therapy: Scaling and root planing on one side and scaling and root planing along with low level laser therapy on the opposite side is done in fi

Sponsors

Dr Ananya Elchuri
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subjects with confirmed diagnosis of Type 2 Diabetes Mellitus with HbA1c levels >=6.5% and on medication for the same. Currently under the care of a physician for Diabetes management. No change in diabetes related medications during 3 months duration prior to enrolment. Subjects with minimum complement of 20 teeth. Subjects who possesses at least two non adjacent sites with probing pocket depths(PPD) of >=5 mm.

Exclusion criteria

Exclusion criteria: • Patients with any other systemic diseases or condition(other than type2 Diabetes Mellitus) which would influence the course of periodontal disease or treatment. • Patients with medical conditions that would require antibiotic prophylaxis for routine dental procedure. • Patients who have taken antibiotics in previous 3 months. • Pregnant or lactating women. • Patients using any form of tobacco products. • Patients who change the medications and or the dose during the course of the study.

Design outcomes

Primary

MeasureTime frame
Reduction in the clinical parameters and Advanced Glycation End Product LevelsTimepoint: Reduction in the clinical parameters and Advanced Glycation End Product Levels at 4 weeks and at 12 weeks—

Secondary

MeasureTime frame
Reduction in the clinical parameters and Advanced Glycation End Product Levels in group with low level laser therapyTimepoint: Reduction in the clinical parameters and Advanced Glycation End Product Levels in group with low level laser therapy at 12 weeks.—

Countries

India

Contacts

Public ContactDr Radhika B

Coorg Institute Of Dental Sciences

ananyaelchuri@gmail.com9986055106

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026